Event
Brenna Jenny and Sean Griffin Speaking on Washington Legal Foundation Webinar
Wednesday, August 28, 2024
Event Details
DateWednesday, August 28, 2024
Sidley partners Brenna Jenny and Sean Griffin will be speaking on a webinar hosted by the Washington Legal Foundation titled, “High Court’s Healthcare Impact: Fines, FDA Authority, and More Post-Loper Bright and Jarkesy” on August 28, 2024 at 1:00 p.m. - 2:00 p.m. ET.
The Supreme Court’s June 2024 pronouncements on judicial deference and the Seventh Amendment created new opportunities and risks for businesses regulated by HHS, including FDA and CMS. Our speakers will leverage directly relevant private and public client representation to assess the opportunities, which include challenging HHS regulatory overreach and seeking adjudication of civil monetary penalties in courts rather than in-house agency processes, and the risks, such as less predictability in drug approval and a shift to equitable forms of remedies.
The Supreme Court’s June 2024 pronouncements on judicial deference and the Seventh Amendment created new opportunities and risks for businesses regulated by HHS, including FDA and CMS. Our speakers will leverage directly relevant private and public client representation to assess the opportunities, which include challenging HHS regulatory overreach and seeking adjudication of civil monetary penalties in courts rather than in-house agency processes, and the risks, such as less predictability in drug approval and a shift to equitable forms of remedies.
Offices
Capabilities
Suggested News & Insights
Recharge & Recaffeinate with Sidley @ JPMMonday, January 12, 2026 – Tuesday, January 13, 2026Biotech Dealmaking – Regulatory Considerations for the Next Wave of Development-Stage Transactions – Program and Lunch @ JPM 2026Monday, January 12, 2026Sidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease TherapyDecember 18, 2025Sidley Represents Immunovant in US$550 Million OfferingDecember 12, 2025BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
